FDA

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

This decision comes after the FDA granted full approval to Pfizer's vaccine earlier this week.

The bill is set for a hearing Tuesday.

The health department will be giving away $100 Visa or Mastercard gift cards to residents who receive their first dose of any COVID-19 vaccine.

The FDA is expected to authorize use of the Pfizer COVID-19 vaccine for children ages 12 to 15 within the next week.

Researchers began studying the use of convalescent plasma several weeks ago as a possible treatment for COVID-19. Labs in Dayton are collecting...

Here are your morning headlines for Monday, March 30:FDA revises rule for sanitizing N-95 masks;Ohio COVID-19 cases approach 2,000;Severe weather spawns…

The Food and Drug Administration has given the go-ahead to Columbus-based Battelle for its full request to sterilize 80,000 N-95 surgical masks per...

Here are your morning headlines for Wednesday, Jan. 29:$10M Summit Lake plan moves forward;University of Akron event canceled amid coronavirus…